Extended duration of the detectable stage by adding HPV test in cervical cancer screening

about

Trends of cervical cancer in Greenland: a 60-year overview.Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial.

P2860

Q38186781-6D7362A5-2BFE-4EE9-AA44-2DD662897B6C Q40471804-A54FEDB6-27B6-4C5A-BADD-43B1C92D89C5

P2860

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

Item

http://www.wikidata.org/entity/Q36671682

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

@ast

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

@en

type

Item

label

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

@ast

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

@en

prefLabel

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

@ast

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

@en

P1476

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

@en

P2093

C J L M Meijer

http://www.w3.org/2001/XMLSchema#string

J D F Habbema

http://www.w3.org/2001/XMLSchema#string

L Rozendaal

http://www.w3.org/2001/XMLSchema#string

M van Ballegooijen

http://www.w3.org/2001/XMLSchema#string

P2860

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.

A systematic review of the role of human papillomavirus testing within a cervical screening programme.

Cervical cytology after 2000: where to go?

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes.

Predicting mortality from cervical cancer after negative smear test results.

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer.

Natural history of cervical neoplasia: consistent results obtained by an identification technique.

HPV testing in primary screening of older women.

Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.

P2888

sj.bjc.6601355

P304

1830-1833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601355

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elske van den Akker-van Marle

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9012849

http://www.w3.org/2001/XMLSchema#string

P698

14612887

http://www.w3.org/2001/XMLSchema#string

P932

2394464

http://www.w3.org/2001/XMLSchema#string

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

about

P2860

P2860

Extended duration of the detectable stage by adding HPV test in cervical cancer screening

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932